🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Sulfur burps protocol — what worked for you?

Sulfur burps protocol — what worked for you?

mike_mealprep Tue, Dec 9, 2025 at 12:19 PM 8 replies 1,020 viewsPage 1 of 2
This thread is more than 6 months old. Information may be outdated. Consider searching for more recent discussions.
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Dec 9, 2025 at 12:19 PM#1

Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

Trial-level incidence runs roughly 20 to 25% for nausea at the higher dose tiers and 12 to 17% for diarrhoea, with most events mild to moderate and concentrated in the weeks after each escalation.

The question I want answered is what distinguishes the nausea you can titrate through from the nausea that means stop.

Practical detail welcome, however dull — the duller the better.

10 13mia_MS2, LeilaHI, marcus_mpls and 7 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Dec 9, 2025 at 1:08 PM#2

Taking the question as asked, rather than the general version of it. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

Last edited: Dec 9, 2025 at 7:08 PM
11 14PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 8 others
Reply Quote Save Share Report
LarryQC_SD
Senior Member
2,123
9,876
Jan 2024
San Diego, CA
Dec 9, 2025 at 1:57 PM#3
Dr.ObesityMed said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

12 15TinaHashiRN, robert_kc, dan_philly and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Dec 9, 2025 at 2:46 PM#4
mike_mealprep said:
Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

Same position here, arrived at the long way round. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Last edited: Dec 9, 2025 at 7:46 PM
13 16LibrarianMeg, bri_stats, pete_manc_UK and 10 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Dec 9, 2025 at 7:24 PM#5

From the other side of the consultation, briefly. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

14 17bbq_ray_KC, oliver_london, tane_welly and 11 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register